Zobrazeno 1 - 10
of 154
pro vyhledávání: ''
Autor:
Paul Mitchell, G Rivalland, Hui Yu, Fred R. Hirsch, R. Mosher, L Churilov, K Asadi, Christopher J. Rivard, S Heynemann
Publikováno v:
Clinical Lung Cancer. 23:e90-e98
Background NaPi2b is a multi-transmembrane sodium-dependent phosphate transporter expressed at normal levels in several organs, including lung. High expression levels have been reported in various tumours including breast, thyroid, ovarian and non-sm
Autor:
Xingpeng Han, Yin Li, Jian Hu, Yang Liu, Xiangning Fu, Xin Peng, Xiaofei Li, Tianyu He, Lunxu Liu, Heng Zhao, Yihe Wu, Jinming Xu, Deruo Liu, Lin Xu, Jinlin Cao
Publikováno v:
Clinical Lung Cancer. 23:170-176
Background Video-assisted thoracic surgery (VATS) has been widely used in the surgical treatment of thoracic diseases, and it suggested surgical and oncological advantages compared with open surgery. However, reports on the application of VATS in sur
Autor:
Yohei Masugi, Hirokazu Matsushita, Hiroaki Kuroda, Yusuke Takahashi, Takao Shigenobu, Ryutaro Hanawa, Atsushi Tajima
Publikováno v:
Clinical Lung Cancer. 22:e820-e828
Histologic subtyping offers some prognostic value in lung adenocarcinoma. We thus hypothesized that histologic subtypes may be useful for risk stratification of brain metastasis (BM). In this study, we aimed to investigate the impact of histologic su
Autor:
Xavier Quantin, Nicolas Girard, Marylise Ginoux, Luc Thiberville, Benjamin Besse, Christelle Clément-Duchêne, P.A. Thomas, P. Mordant, Angela Botticella, C. Le Pechoux, J. Khalifa, Eric Pichon, Thierry Jo Molina, F. Le Tinier, Youssef Oulkhouir, Mallorie Kerjouan, Clémence Basse, Pierre Emmanuel Falcoz, F. Thillays, Virginie Westeel
Publikováno v:
Clinical Lung Cancer
Clinical Lung Cancer, Elsevier, 2021, ⟨10.1016/j.cllc.2021.01.020⟩
Clinical Lung Cancer, Elsevier, 2021, ⟨10.1016/j.cllc.2021.01.020⟩
Introduction Thymomas are rare intrathoracic malignancies that may be aggressive and difficult to treat. Knowledge and level of evidence for treatment strategies are mainly based on retrospective studies or expert opinion. Currently there is no stron
Publikováno v:
Clinical Lung Cancer. 22:e595-e601
Background Thoracic vascular structures often preclude transbronchial access to central lung parenchymal lesions and lymph nodes, thereby necessitating either a surgical or transvascular needle aspiration (TVNA) approach for diagnostic sampling. The
Publikováno v:
Clinical Lung Cancer. 22:e646-e653
Background Non-small cell lung cancer (NSCLC) is responsible for the most cancer-related deaths in the United States. A better understanding of treatment-related disparities and ways to address them are important to improving survival for patients wi
Autor:
Noboru Oriuchi, Ryohei Yamamoto, Yukitoshi Satoh, Akihiro Ichikawa, Satoshi Shiozawa, Nobuhiro Nishizawa, Hideki Endoh
Publikováno v:
Clinical Lung Cancer. 22:218-224
Introduction 2-[18F] Fluoro- d -deoxyglucose (FDG) positron emission tomography (PET) is a relevant diagnostic procedure for staging lung cancer. However, accurate evaluation of lymph node metastases by PET is controversial because of false-positive
Autor:
Kevin L. Stephans, Sarah M.C. Sittenfeld, Gregory M.M. Videtic, Chandana A. Reddy, Aditya Juloori
Publikováno v:
Clinical Lung Cancer. 22:e360-e365
Introduction We sought to evaluate the safety and efficacy of stereotactic body radiation therapy (SBRT) as salvage treatment for local recurrence after prior surgical resection for non–small-cell lung cancer (NSCLC). Materials and Methods We surve
Publikováno v:
Clinical Lung Cancer. 22:e301-e312
Background /Purpose: We report our clinical outcomes of patients with recurrent non-small cell lung cancer (NSCLC) tumors with ultra-central (UC) location treated with hypofractionated 10 fraction stereotactic body radiotherapy (hSBRT) in the context
Publikováno v:
Clinical Lung Cancer. 22:e878-e880
Clinical Practice Points • The incidence of non–small cell lung cancer with primary BRAF fusions is rare, and no therapeutics are approved to treat these gene alterations. • Herein, we report the first case with advanced lung adenocarcinoma har